MPE Report: Assessment of the needs of patient organisations during the COVID-19 pandemic

Assessment of the needs of patient organisations during the COVID-19 pandemic


As the SARS-CoV-2 (COVID-19) pandemic unfolded in 2020, Myeloma Patients Europe (MPE) became aware that the pandemic, as well as the restrictions imposed, were impacting the healthcare and lives of people with myeloma and AL amyloidosis, and their caregivers in multiple ways. The crisis also brought unique challenges to our member organisations in connecting with and supporting their patient communities.

To understand how we could best help, MPE conducted research to learn more about the impact of the pandemic and lockdown measures, and the needs of patients, carers and member organisations. A survey of 28 members in April 2021 revealed a significant emotional and psychosocial impact, as well as treatment delays and problems accessing wider healthcare and support services in some countries. Although members were adapting, some had concerns over their financial resilience and future organisational sustainability.

This report summarises the main issues and challenges European myeloma patient organisations have faced during the current COVID-19 pandemic. Thank you to the representatives of MPE member organisations for their time and contributions to this survey.

Read the full report here.

Read more information about COVID-19 and myeloma and AL amyloidosis in the MPE COVID-19 section.
Impact of COVID-19 on myeloma and AL amyloidosis patients

Through our COVID-19 Outreach Workstream, and as part of our mission to provide education, information, and support to members and to advocate at European, national, and local levels, MPE began research to learn more about the effects of COVID-19 on the patient community.

MPE has published a report summarising the results of a series of semi-structured focus groups conducted to collect personal experiences and broader insights from patients and caregivers.

Read this report here.
Myeloma Patients Europe


Zagreb, HR

Hrvatska udruga leukemija i limfomi
predsjednik Dražen Vincek
Trg hrvatskih velikana 2/ll
10 000 Zagreb
GSM: +385 (0)91 4873 561
TEL: +385 (0)1 4873 561
Web adresa:
IBAN: HR 36 2340 0091 1100 4711 4

Važni datumi


Health through Knowledge

Klasa optimist

Istaknuti sponzori HULL-a